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Depression in Parkinson’s disease (PD) is frequently associated with executive deﬁcits, which can inﬂuence nonliteral com-
prehension and lexical access. This study explores whether depressive symptoms in PD modulate verbal ﬂuency and nonliteral
language comprehension. Twelve individuals with PD without depressive symptoms, 13 with PD and depressive symptoms
(PDDSs), and 13 healthy controls completed a semantic and phonemic verbal ﬂuency task and an indirect speech acts
comprehension task. All groups had the same performance in the phonemic ﬂuency task while the PDDS group was impaired
in the semantic task. For the indirect speech act comprehension task, no diﬀerence was observed between the groups. However,
the PDDS group had diﬃculty answering direct speech act questions. As some language impairments in PD become apparent
when depressive symptoms are associated with the disease, it would appear to be important to take the presence of depressive
symptoms into account when evaluating language abilities in PD.
1.Introduction
The most frequently reported nonmotor symptoms in non-
demented individuals with Parkinson’s disease (PD) are
psychiatric deﬁcits (such as depression, apathy [1], and sleep
disturbances [2]) and cognitive impairments (e.g., executive
functions [3] and language deﬁcits [4]). Depression, a symp-
tom reported in approximately 27% to 40% of individuals
withPD[5],hasbeenshowntoincreasemotorsymptoms[1]
and cognitive impairments [6], to be associated with more
rapid disease progression [7], and to diminish quality of life
[8]. As is already known, depressive symptoms are frequently
associated with executive deﬁcits [9] ,w h i c hi nt u r nc a n
inﬂuence the participant’s performance in other cognitive
situations such as abilities involving high-level language
processing. Indeed, non-literal language comprehension and
lexical access (verbal ﬂuency) are largely dependent on exec-
utive functions [10]. Non-literal language (such as indirect
speech acts, metaphors, or irony) comprehension requires
inhibitingandgoingbeyondtheliteralmeaningofasentence
according to the context [11]. As for verbal ﬂuency, this
ability involves the retrieval of semantically or phonemically
related words from a subcategory (clustering) and then
switching to a new subcategory, which requires both mental
ﬂexibility and inhibition abilities [12].
Language disabilities are reported in approximately half
of individuals with PD. For instance, individuals with PD
may have diﬃculties with semantic [13], syntactic [14], lexi-
calaccess[15],prosodic[16],andnon-literalcomprehension
abilities [17]. It is well known that PD is heterogeneous in
regards to language abilities and other cognitive domains,
such as memory or executive deﬁcits. To understand this
cognitive heterogeneity, many authors have tried to identify
subgroups of individuals with PD principally according to
the predominant motor symptoms [18] and the presence
or absence of depression [19–21]. Studies have shown
that individuals with PD who were depressed had more
severe cognitive impairments than others [19]. Many studies2 Parkinson’s Disease
have shown an important association between depressive
symptoms and cognitive impairments such as executive and
memory deﬁcits [9, 22, 23]. Tr¨ oster et al. suggested that
depression tends to increase the severity of cognitive deﬁcits
caused by PD but does not add new ones [24]. The study
of Fernandez et al. also supported previous studies results
suggesting that depressive symptoms in PD are associated
with global cognitive impairments (as demonstrated by the
signiﬁcant correlation observed between BDI and MMSE
scores) [25]. However, when they looked at the scores
obtained in speciﬁc cognitive domains (attention, verbal
memory, language, executive functions, and visual-spatial
processing) by participants with PD, they found that only
verbal memory and language performance (i.e., Hopkins
Verbal Learning Test delayed recall and Boston Naming
Test scores) showed a signiﬁcant correlation with depressive
symptoms. Thus, one could expect verbal ﬂuency and non-
literal language comprehension deﬁcits to be exacerbated
by depressive symptoms in PD. If this is the case, treating
depressive symptoms in PD may improve speciﬁc cognitive
and language abilities.
The main purpose of this study was to investigate wheth-
er depressive symptoms in nondemented individuals with
PD modulate verbal ﬂuency and non-literal language com-
prehension. Based on previous studies, we anticipated that
these two abilities would be problematic for individuals
with PD [16, 26], but that performance would be negatively
inﬂuenced by depressive symptoms.
2.MaterialsandMethods
2.1. Participants. Twenty-ﬁve individuals diagnosed with
idiopathic PD (mean ± SD age: 63±6y e a r s ;e d u c a t i o n :1 4 ±
3 years; 9 women and 16 men) participated in this study.
The diagnosis of idiopathic PD was made by a movement
disorder neurologist on the basis of accepted motor criteria
[27]. Motor disability of individuals within the PD group
was in the mild-to-moderate severity range (I–III) according
to the Hoehn and Yahr (H&Y) staging criteria [28]a n d
was also evaluated with UPDRS-III (Uniﬁed Parkinson’s
Disease Rating Scale part III) (mean ± SD: 29.92 ± 9.05)
[29]. In addition to their dopaminergic medication, some
participants were taking other medication as follows: ven-
lafaxine 112.5mg/day (n = 1), citalopram 60mg/day (n =
1), irbesartan (n = 1), levothyroxine (n = 1), rosuvastatin
calcium (n = 1), amphetamine (n = 1), atorvastatin (n = 3),
warfarine (n = 1), folic acid (n = 1), sotalol (n = 1),
hydrochlorothiazide (n = 1), and metformin (n = 1).
Participants with PD were divided into two subgroups
according to their depression level: 12 without depressive
symptoms (PD) and 13 with depressive symptoms (PDDS).
The Beck Depression Inventory (BDI-II) was used to assess
depressive symptoms in all participants [30]. The BDI-II is a
21-question, multiple choice, self-report inventory covering
cognitive, behavioral, and somatic aspects of depression. The
BDI was selected as the measure of depressive symptoms
because of its reliability in identifying depression in older
adults [31] and PD individuals [32]. To have the maximum
sensibility to screen for depressive symptoms, the cut-oﬀ
score of 8/9 was used [33].
The two groups of patients with PD were compared to 13
healthycontrols(HCs)withoutdepression.Participantswith
history of alcohol abuse or neurological disease other than
depression and PD were systematically excluded. All indi-
viduals were screened for dementia prior to the experiment
using the Montreal Cognitive Assessment (MoCA) [34]. If
their score was <26, they were also excluded of the study,
but none of the participants met the criteria for dementia.
All participants had normal or corrected-to-normal vision as
determined by self-report.
2.2. Materials and Procedure. An informed consent was
obtained for experimentation with human subject and
participants were compensated for their participation. Tests
were approved by the ethics committee of the University of
Montreal and administered according to these committee
guidelines. The privacy rights of each participant were
always observed. Participants were evaluated individually in
a quiet room during a two-hour session. As performance on
cognitive and language tasks is typically inﬂuenced by Lev-
odopa therapy [35], all participants with PD were evaluated
while they were oﬀ their dopaminergic medications (at least
12 hours following withdrawal). All tests, including H&Y,
UPDRS-III, BDI-II, and MoCA, were performed without
dopaminergic medications.
2.3. Neuropsychological Tests. Participants completed a bat-
tery of standardized neuropsychological tests, which in-
cluded measures estimating executive resource functions.
Three diﬀerent measures linked to executive dysfunctions
generallyfoundinPDwereused:processingspeed,planning,
andinhibition.Tomeasureprocessingspeed,theﬁrstsubtask
oftheStroopColorWordTest[36]andtheTrail-MakingTest
A[ 37] were used. In the Stroop Color Word Test (subtask
1), the time required to read 100 color names appearing
in black on a sheet was recorded and the scores were then
converted in the number of words said in 45sec. The time
make to complete the part A of the task was also recorded in
the Trail Making Test to measure the processing speed. The
number of errors in the Tower of London test [38]w a su s e d
tomeasureplanning.Theinhibitionscorewasevaluatedwith
the Hayling test part B [39] and the third subtask of the
Stroop Color Word Test (number of errors in both cases).
The error score in the Stroop Color Word Test was calculated
as the number of errors in the inhibition condition (subtask
3) minus the number of errors in the control condition.
Moreover,theBrixtonSpatialAnticipationTestwasalsoused
to measure anticipation, mental ﬂexibility, and set-shifting
[40].
2.4. Language Tasks. Participants completed two tasks evalu-
ating language abilities.
2.4.1. Verbal Fluency Tasks. Participants were evaluated on
a semantic and a phonemic verbal ﬂuency task from the
Montreal Evaluation of Communication (MEC) protocolParkinson’s Disease 3
[41]. For the phonemic verbal ﬂuency task, participants
had to say as many words as possible starting with the
letter “F” in two minutes. Proper names, repeated words,
and morphologically derived words were rejected. For the
semantic verbal ﬂuency task, participants had to name as
many items of clothing as possible in two minutes. The
number of words said in this lap of time was recorded and
analyzed in both tasks.
2.4.2. Nonliteral Language Comprehension Task. An indirect
speech act task from the MEC Protocol [41]w a su s e d
to evaluate non-literal language comprehension. This task
includes short stories that refer to everyday-life situations
where the intention of the person is not explicitly mentioned
with reference to a context (e.g., “John is in his bedroom
listening to music. His dad tells him: John, your door is
open. What do you think his father means?”), or where the
person says explicitly what they wanted to say (e.g., “Mr.
Larsenworksinanoﬃceandisprintingadocument.Hesays
to his secretary: This printer is very eﬃcient. What do you
think Mr. Larsen means?”). An explanation and an example
of questions with indirect and direct speech acts were given
verbally by the experimenter to familiarize participants with
the procedure before beginning the test. Participants were
instructed to listen to the stories and respond verbally to the
questions. Twenty stories (half indirect and half direct) were
presented to each individual in a random order.
2.5. Statistical Analyses. Taking into account the normality
of data distribution, the analyses were conducted using
ANOVA and the Tukey or the Games-Howell post hoc
tests to compare the data between the three groups. Mann-
Whitney test was performed for dichotomous variables.
Relationships between variables were investigated with the
Spearman rank correlation test because the indirect speech
act scores were not normally distributed. All raw scores were
converted to z-scores, taking into account the mean and the
standard deviation of the control group scores, to calculate
correlations. The results were considered signiﬁcant if P<
0.05.Asitisknownthatantidepressantdrugscouldinﬂuence
individual’s cognitive performance, all analyses were also
performed excluding the two participants that were taking
medication for depression (venlafaxine and citalopram). As
no diﬀerence was found between the signiﬁcativity of the
results with or without these participants, both participants
were included in the present statistical analysis.
3. Results
3.1. Demographic and Clinical Data. Table 1 reports the clin-
icalandsociodemographiccharacteristicsoftheparticipants.
In the present study, the HC and PD groups did not have
signiﬁcant depressive symptoms (BDI scores between 0 and
7) while the PDDS group had mild-moderate depressive
symptoms (BDI: 10 to 28), a highly signiﬁcant diﬀerence
(F(2,35) = 40.77, P<0.001). The PD and PDDS groups
were comparable on age (F(2,35) = 1.48, P = 0.24) and
education (F(2,34) = 1.12, P = 0.34) with the HC group.
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Figure 1: Phonemic and semantic verbal ﬂuency mean results
(±SEM) for participants with Parkinson’s disease with (white
column) and without (grey column) depressive symptoms and
healthy controls (black column).
The two patients’ groups were also comparable on disease
duration (P = 0.22), age at disease onset (P = 0.69), and
UPDRS-III (P = 0.17), factors known to inﬂuence cognitive
abilities in PD [42–44].
The results for verbal ﬂuency, non-literal comprehen-
sion, and on the neuropsychological tests are reported
separately in the next three subsections.
3.2. Verbal Fluency. Figure 1 presents the mean numbers
of words produced in the phonemic and semantic verbal
ﬂuency tasks for the HC group and both PD groups.
The ANOVA revealed a signiﬁcant diﬀerence between the
three groups (PD, PDDS, HC) for semantic verbal ﬂuency
(F(2,34) = 3.64, P = 0.04). Interestingly, the scores of
PDDS in this task were signiﬁcantly diﬀerent than those of
the HC group (P = 0.03) whilst there was no signiﬁcant
diﬀerence in the number of words produced by HC and PD
participants(P = 0.28)asindicatedbyposthoccomparisons
using Tukey test. In the phonemic verbal ﬂuency task, there
wasnosigniﬁcantdiﬀerencebetweentheHCandthetwoPD
groups (F(2,34) = 98.23, P = 0.15).
3.3. Nonliteral Language Comprehension. Figure 2 reports
the accuracy in answering direct and indirect questions for
the three groups of participants. There were no signiﬁcant
diﬀerences for indirect speech acts between the three groups
(F(2,34) = 1.21, P = 0.31). However, the ANOVA
conducted to compare the mean scores for direct speech acts
revealed a signiﬁcant diﬀerence between the three groups
(F(2,35) = 9.61, P<0.001). Furthermore, post hoc
comparisons using the Tukey test indicated that the PDDS
group’s direct speech act results were signiﬁcantly lower than
thescoresofbothPD(P = 0.02)andHC(P<0.001)groups.
The mean score of PD and HC was not signiﬁcantly diﬀerent
(P = 0.38).4 Parkinson’s Disease
Table 1: Demographic and clinical characteristics of healthy controls (HCs) and participants with Parkinson’s disease with (PDDS) and
without (PD) depressive symptoms.
Features
Groups
Signiﬁcant diﬀerence
with HC
HC
Mean (SD)
PD
Mean (SD)
PDDS
Mean (SD)
Age (years) 61,94 (5,62) 61,81 (4,81) 64,77 (6,00) NSa
Education (years) 14,85 (3,37) 13,00 (2,72) 14,23 (2,77) NS
Gender (% men) 30,77 50,00 76,92 PDDS∗
Disease duration (years) — 4,42 (3,00) 6,31 (4,25) NS
Age at onset (years) — 57,39 (6,86) 58,46 (6,32) NS
Montreal Cognitive Assessment (MoCA) 28,38 (1,27) 28,08 (1,16) 27,15 (1,77) NS
UPDRS-III — 26,58 (7,88) 33,00 (9,24) NS
Beck Depression Inventory (BDI) 2,92 (2,25) 4,17 (2,12) 14,54 (5,32) PDDS∗∗∗
All tests were performed without dopaminergic medication.
aNS (non-signiﬁcant); ∗P<0.05; ∗∗∗P<0.001.
No results are signiﬁcantly diﬀerent between PDDS and PD except for BDI (P<0.001).
UPDRS: Uniﬁed Parkinson’s Disease Rating Scale.
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Figure 2: Direct and indirect speech act mean results (±SEM)
for participants with Parkinson’s disease with (white column) and
without (grey column) depressive symptoms and healthy controls
(black column).
3.4. Neuropsychological Tests and Their Correlation with Lan-
guage. Table 2 presents the neuropsychological performance
of healthy controls, PDDS, and PD participants. Statistical
comparisons performed on the neuropsychological tests
results of the three groups revealed only one signiﬁcant
diﬀerence between PDDS and PD, and PDDS and HC on
the Tower of London test (number of errors) (F(2,35) =
29.71,P = 0.003).TheGames-Howellposthoctestindicated
that the PDDS group made signiﬁcantly more errors than
the PD group (P = 0.047). Moreover, this post hoc test
revealed a signiﬁcant diﬀerence on the Tower of London
scores (number of errors) between PDDS and HC groups
(P = 0.04), while there was no diﬀerence between PD and
HC (P = 0.87). Taken together, these results indicate that
Parkinson’s disease with depressive symptoms has a negative
eﬀect on planning ability (as evaluated by the Tower of
London test), but that Parkinson’s disease itself has no eﬀect
onthiscapacity.ScoresobtainedbythePDandPDDSgroups
were similar to HC scores on the Stroop (number of words
and number of errors) test, the Color Trail-Making Test A,
and the Hayling test, evaluating inhibition and processing
speed. However, statistical analysis revealed a signiﬁcant
diﬀerence on the Brixton Spatial Anticipation Test between
groups (F(2,35) = 4.90, P = 0.01). Post hoc comparisons
using the Tukey test indicated that the mean score for the
Brixton Spatial Anticipation Test was signiﬁcantly diﬀerent
between PDDS and HC groups (P = 0.02) as well as between
PD and HC participants (P = 0.03).
To verify if these executive impairments aﬀected perfor-
mance in language tasks, correlations between direct speech
acts, semantic verbal ﬂuency results, and selected composite
scores were calculated. Prior to the analyses, raw data from
the neuropsychological tests were transformed into z scores,
taking into account the control group performance. Then
composite scores were calculated to estimate the patients’
capacities in processing speed (performance in the ﬁrst
subtask of the Stroop [number of words] and Color Trail-
Making Test A [time]) and inhibition (performance in
the third subtask of the Stroop [number of errors] and
in the part B of the Hayling [number of errors]). No
composite score was calculated for estimate the participants’
abilities in planning because only one test was taken into
account (performance in the Tower of London [number of
errors]). Spearman’s test showed that the direct speech act
resultsweresigniﬁcantlycorrelatedwithinhibitionforPDDS
participants only (r(7) = 0.64, P = 0.03). Moreover, a
signiﬁcant correlation was found between the number of
words produced in the semantic verbal ﬂuency task and
processing speed only for the PDDS group (r(7) = 0.85,
P = 0.002).
3.5. Correlations between Clinical Features. Correlations be-
tween language test results (direct and indirect speech act
scores, and phonemic and semantic verbal ﬂuency scores)
and demographic characteristics (age, education, gender,Parkinson’s Disease 5
Table 2: Neuropsychological performance of healthy controls (HCs) and participants with Parkinson’s disease with (PDDS) and without
(PD) depressive symptoms.
Tests of executive resources
Groups
Signiﬁcant diﬀerence
with HC
HC
Mean (SD)
PD
Mean (SD)
PDDS
Mean (SD)
Stroop color word test (number of words) 48,77 (10,57) 48,64 (6,64) 44,18 (7,40) aNS
Stroop color word test (number of errors) 0,38 (0,77) 1,36 (1,57) 1,17 (1,53) NS
Color trail-making test A 34,08 (8,98) 36,10 (13,76) 44,85 (17,44) NS
Hayling 4,58 (1,88) 3,73 (1,74) 3,83 (1,64) NS
London tower (number of errors) 0,46 (0,52) 0,58 (0,67) 3,15 (3,39) PDDS∗
Brixton spatial anticipation test 7,00 (2,27) 4,75 (2,01) 4,69 (2,10) PDDS∗,P D ∗
All tests were performed without dopaminergic medication.
aNS (non-signiﬁcant); ∗∗P<0.01; ∗P<0.05.
No results are signiﬁcantly diﬀerent between PDDS and PD except for the Tower of London (number of errors; P<0.05).
disease duration, age at onset, MoCA, UPDRS-III, and
BDI) were investigated for HC, PD, and PDDS groups.
Only one signiﬁcant correlation was found for the PDDS
group, in this case between the direct speech act results
and BDI scores (r(11) =− 0.59, P = 0.03), showing the
inﬂuence of depressive symptoms on the interpretation of
direct speech acts. Even if the percentage of men diﬀered
signiﬁcantlybetweenHCandthePDDSgroups(seeTable 1),
no signiﬁcant correlation was found between gender and
language test results for both groups, suggesting that gender
did not inﬂuence the language abilities evaluated. In fact,
no signiﬁcant correlation was found between language test
results and all demographic characteristics for both HC and
PD groups.
4. Discussion
The goal of this study was to investigate whether depressive
symptoms are associated with diﬀerent patterns of perfor-
mance on verbal ﬂuency and non-literal language com-
prehension tasks in nondemented individuals with PD. No
diﬀerence was observed between HC, PD, and PDDS groups
inthephonemicﬂuencytaskwhileonlythePDDSgroupwas
impaired in the semantic ﬂuency task. An association was
observed between the number of words produced in this task
andtheprocessingspeedscores.Moreover,allgroupshadthe
same performance in the indirect speech act comprehension
task, but only the PDDS group had diﬃculty answering
direct speech act questions. Interestingly, PDDS group scores
on direct speech act questions were only associated with
inhibition abilities. These ﬁndings support Fernandez et al.
studyshowingthatwhiledepressivesymptomscorrelatewith
global cognitive performance, language abilities seem to be
themostsusceptiblecognitivedomainsaﬀectedbydepressive
symptoms [25].
4.1. Verbal Fluency. With respect to verbal ﬂuency tasks,
results showed that both PD subgroups had a good perfor-
mance for phonemic ﬂuency. Although there are controver-
sial results in the literature about phonemic ﬂuency in indi-
viduals with PD [45, 46], our results are in agreement with
mostofthepreviousstudies[26,47],suggestingthatPDwith
orwithoutdepressivesymptomsdonotimpairthephonemic
verbal ﬂuency capacities. However, our results showed that
only the PDDS group was impaired on the semantic ﬂuency
task while the PD group’s performance was comparable
to the HC group. Most of the literature showed impaired
semantic ﬂuency for nondemented individuals with PD [15,
26, 47], but mild-to-moderate depressive symptoms were
not taken into account in these researches. Our results thus
suggested that semantic ﬂuency is modulated by depressive
symptomswhilephonemicﬂuencyisnot,whichissomewhat
odd because depressive symptoms are generally associated
with executive deﬁcits [25] and phonemic ﬂuency is known
to require more executive capacities than semantic ﬂuency
[14]. One possible explanation may be that these PD patients
have particular semantic deﬁcits in addition to speciﬁc
cognitive deﬁcits (such as processing speed decrement, as
supported by the signiﬁcant correlation found between the
number of words produced in the semantic ﬂuency task and
the processing speed scores) leading to more diﬃculties to
quickly ﬁnd words semantically related. Indeed, Portin et
al. found that only PD patients with mild cognitive deﬁcits
have a storage impairment of semantic knowledge [48].
They observed that PD participants with mild cognitive
impairments performed worse than PD patients without
cognitive deﬁcits in deﬁning concrete and abstract concepts
and in tasks demanding evaluation of hierarchical semantic
relations.However,otherinvestigationsexploringtheimpact
of diﬀerent cognitive deﬁcits combined to speciﬁc semantic
impairments on verbal ﬂuency in PD would be necessary to
conﬁrm this hypothesis.
4.2. Nonliteral Language Comprehension. Comprehension
of indirect speech acts in individuals with PD was also
evaluated since previous studies showed that more than
half of them presented non-literal language understanding
deﬁcits [16, 49]. No signiﬁcant diﬀerence was observed for
indirect speech act comprehension between the scores of
PD, PDDS, and HC. So neither PD nor mild-to-moderate
depressive symptoms in PD seemed to have any inﬂuence on
indirect speech act comprehension in this oﬄine task. In an6 Parkinson’s Disease
online experiment, McNamara et al. observed an ineﬃcient
activation of indirect meaning of indirect speech acts and
a correlation with participants’ executive dysfunctions [50].
However, in a second experiment conducted oﬄine by the
same researchers, no signiﬁcant diﬀerence was showed for
indirect speech acts comprehension between PD and control
groups. McNamara et al. concluded that PD and control did
not diﬀer in their interpretation of indirect speech acts, but
that activation speed of indirect meanings was slower for
PD participants than for control. Our results are consistent
with the oﬄine results of McNamara’s study, indicating no
impairment in indirect speech act comprehension for the PD
participants,whetherornottheyshowdepressivesymptoms.
Surprisingly, our results showed a signiﬁcant diﬀerence
in direct speech act scores between HC and PDDS partic-
ipants. We found that only the PDDS group had diﬃculty
answering direct speech act questions while the PD group
performed like the HC individuals. This unexpected result
was also found in previous study with a right-hemisphere-
damaged population [51]. Researchers have suggested that
participants’impairmentinthedirectspeechactswascaused
by their inhibition deﬁcit preventing them from inhibiting
irrelevantinformationandleadingtheparticipantstooverat-
tribute intention to the protagonist and to understand direct
speech acts as indirect ones. As we found in the present study
that inhibition scores correlated signiﬁcantly with PDDS
direct speech act results, this explanation is also applicable
for the PDDS participants. However, further investigations
with more participants would be necessary to conﬁrm this
hypothesis.
As previously presented, this study showed that semantic
ﬂuency and planning ability in PD become apparent or more
severe when depressive symptoms are associated with the
disease (as shown by the ﬂuency and the Tower of London
results, resp.). These ﬁndings suggested that depressive
symptoms in PD would be related to speciﬁc neuropatho-
logical changes. Indeed, many studies argue that depression
in PD seems to result from a degeneration of neurological
pathways (including serotoninergic and dopaminergic neu-
rons) that regulate behavior, cognition, and language [21].
Onecanalsoarguethatcognitivedeﬁcits(includinglanguage
impairments) found in PD with depressive symptoms are
just a manifestation of depression. In fact, Kuzis et al.
(1997) evaluated PDDS individuals and individuals with
depression (MD) but without PD with a comprehensive
neuropsychological and psychiatric assessment [23]. They
reported that PDDS participants had a worse performance
than MD individuals on speciﬁc cognitive tasks such as
concept formation and switching abilities. Their results
showed that cognitive deﬁcits in PDDS group were not only
associated with depression but may be related to speciﬁc
neurological impairments associated with depression in PD.
Some limitations of the present study deserve mention:
(1) the results of this study are only applicable to PD patients
oﬀ medication and should not be generalized directly to PD
patients on medication: other studies are necessary to verify
if medication is an important factor when investigating the
association between language and depressive symptoms in
PD; (2) we have a limited number of participants in each
group; thus further investigations with more participants
would be necessary to generalized the results of this pilot
study to population with PD; (3) to better understand the
role of depression on diﬀerent cognitive abilities (including
language capacities), it would have been interesting to have a
controlgroupwithdepressivesymptomswithoutPD:further
studies on this topic may help to specify which cognitive
deﬁcitsareparticularlyassociatedwithdepressionandwhich
ones are associated with depression and PD.
5. Conclusions
In summary, the results of this present investigation are
in accordance with many studies indicating that depressive
symptoms are negatively associated with cognition in PD.
However, still few studies have explored the relationship
between depressive symptoms and speciﬁc language impair-
ments in PD (e.g., verbal ﬂuency and non-literal language
deﬁcits). Among these studies, the present one is the ﬁrst
to explore the associations between depressive symptoms,
cognitive capacities (such as processing speed and inhi-
bition), and the performance on speciﬁc language tasks
in PD. Indeed, in PD individuals, depression is generally
associated with memory and executive deﬁcits, which can
inﬂuence language abilities. It would therefore be very
important to take the presence of depressive symptoms into
account when evaluating cognitive and language abilities in
individuals with PD. Separately evaluating PD and PDDS
patients would then be an adequate way of taking into
account their diﬀerences. This would help, for example,
to understand what cognitive or language impairments are
caused by PD and which are associated to depression in
PD. Furthermore, other studies evaluating semantic, lexical,
and syntactic abilities would be very useful to specify what
speciﬁc language abilities are associated with depressive
symptoms.
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